| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/13/2003 | US20030032587 Urocortin peptides |
| 02/13/2003 | US20030032187 Selective antibody targeting of undifferentiated stem cells |
| 02/13/2003 | US20030032186 Method for stable chromosomal multi-copy integration of genes |
| 02/13/2003 | US20030032179 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 02/13/2003 | US20030032176 Helper-free stocks of recombinant adeno-associated virus vectors |
| 02/13/2003 | US20030032175 Methods of producing cells and animals comprising targeted gene modifications and compositions relating thereto |
| 02/13/2003 | US20030032169 Nucleotide sequences coding polypeptide for use in the treatment of cancer, skin and vision defects |
| 02/13/2003 | US20030032167 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 02/13/2003 | US20030032166 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 02/13/2003 | US20030032161 Esterase enzymes, DNA encoding esterase enzymes and vectors and host cells incorporating same |
| 02/13/2003 | US20030032160 Nucleotide sequences coding protein for use in treatment of cancer, inflammation, arthritis and psoriasis |
| 02/13/2003 | US20030032159 Human ralgds-like protein 3 |
| 02/13/2003 | US20030032156 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 02/13/2003 | US20030032155 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032153 Novel (R)-2,3-butanediol dehydrogenase, methods for producing same, and methods for producing optically active alcohol using the dehydrogenase |
| 02/13/2003 | US20030032152 Genetically engineered yeast for use in the generation of lactic acid |
| 02/13/2003 | US20030032147 Isolation of preferential nucleotide sequences; obtain sample containing nucleotide sequences, incubate with alkaline, expose to matrix consisting of chaotropic agents, elute and recover preferential nucleotide sequences |
| 02/13/2003 | US20030032146 Enzyme/tag binding and detection system |
| 02/13/2003 | US20030032145 Pharmaceutical compositions including variants of vascular endothelial cell growth factor having altered pharmacological properties |
| 02/13/2003 | US20030032144 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 02/13/2003 | US20030032141 Protein and nucleic acid expression systems |
| 02/13/2003 | US20030032138 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032135 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032119 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032100 Genes encoding desulfurization enzymes |
| 02/13/2003 | US20030032098 Bone morphogenic protein |
| 02/13/2003 | US20030032097 DNA encoding human vanilloid receptor VR3 |
| 02/13/2003 | US20030032095 Novel nucleic acid sequences encoding human semaphorin-like polypeptides |
| 02/13/2003 | US20030032093 Production of secreted polypeptides |
| 02/13/2003 | US20030032092 DNA molecules, preparation and use in gene therapy |
| 02/13/2003 | US20030032091 48120, 23479 and 46689, novel human hydrolases and uses thereof |
| 02/13/2003 | US20030032089 Isolated cocoon silk protein from simulium vittatum and nucleic acids encoding such protein |
| 02/13/2003 | US20030032086 Mixture for use as tool in propagation of nucleotide sequences |
| 02/13/2003 | US20030032085 An expression cassette comprising a transcriptional initiation region, consisting of a 5' non-coding region regulating the transcription of patched protein, a marker gene, and a transcriptional termination region |
| 02/13/2003 | US20030032083 Biosynthesis of preferential peptide; obtain amino acid sequence, ligate protection group, deprotect peptide, recover peptide |
| 02/13/2003 | US20030032075 Monoclonal or recombinant antibody for use in the treatment of tumors |
| 02/13/2003 | US20030032060 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032059 Gene recombination and hybrid protein development |
| 02/13/2003 | US20030032052 Sequencing preferential nucleotide sequences; obtain pattern nucleotide sequence, join to substrate, incubate with reaction mixture, sequence pattern nucleotide sequences |
| 02/13/2003 | US20030032049 Sensitive, multiplexed diagnostic assays for protein analysis |
| 02/13/2003 | US20030032042 Internal calibration standards for electrophoretic analyses |
| 02/13/2003 | US20030032041 Electrochemiluminescence helicase assay |
| 02/13/2003 | US20030032040 Process of quality examining for microarray of biological material |
| 02/13/2003 | US20030032038 AMPA-binding human GluR3 receptors |
| 02/13/2003 | US20030032037 Circular site-directed mutagenesis |
| 02/13/2003 | US20030032032 Diagnosing viral brain disorders; obtain sample nucleic acids, incubate with marker probe, denature, hybridize, detect signal from probe, presence of signal indicates viral infection |
| 02/13/2003 | US20030032026 Detection and measurement of methylated cytosine in nucleic acid sample; obtain genomic nucleotide sequences, incubate with reaction mixture and label, amplifiy nucleotide sequences, detect and quantify fluorescence |
| 02/13/2003 | US20030032023 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 02/13/2003 | US20030032020 Generation of nucleotide sequence library; obtain nucleotide sequences, incubate with enzymes, separate into single nucleotide sequences, hybridize sequences, incubate with nuclease and recover nucleotide sequences |
| 02/13/2003 | US20030032019 Novel G protein-coupled receptors |
| 02/13/2003 | US20030032018 Nucleotide sequences coding preferential plypeptide for use in the diagnosis and treatment of hypertension, hypotension, heart disease, asthma, and the like. |
| 02/13/2003 | US20030032016 Detecting in nucleic acid molecule; obtain oligonucleotide probes, incubate with sample, expose to polymerase, amplify nucleotide sequence, detect signal from probe, recover signaling nucleotide sequences |
| 02/13/2003 | US20030032014 Colony array-based cDNA library normalization by hybridizations of complex RNA probes and gene specific probes |
| 02/13/2003 | US20030032010 Methods of populating data structures for use in evolutionary simulations |
| 02/13/2003 | US20030032009 09007761method for influencing the p53 linkage to target genes |
| 02/13/2003 | US20030032007 Method of detecting microorganisms in a sample |
| 02/13/2003 | US20030032005 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 02/13/2003 | US20030032004 Primers and probes derived from the 5' untranslated region of the HCV genome which facilitate detection and/or quantification of all presently known genotypes of HCV. |
| 02/13/2003 | US20030032003 Recovering preferential cells from solution; obtain cells, transform with expression vector, express vector, detect reporter molecule, recover cells expressing reporter molecule |
| 02/13/2003 | US20030031999 Determining the translational efficiency of an individual codon in a cell; obtain cell, transform with expression vector, express vector, monitor gene expression and translation |
| 02/13/2003 | US20030031704 Liposome composition for delivery of nucleic acid |
| 02/13/2003 | US20030031683 Selecting for a strain of bacteria having an RpoS+ phenotype, inactivating mutations which render the strain attenutated, and a recombinant gene encoding the product |
| 02/13/2003 | US20030031682 Pathogens useful as vaccines for therapy and/ or prophylaxis |
| 02/13/2003 | US20030031681 Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector |
| 02/13/2003 | US20030031679 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 02/13/2003 | US20030031675 For the immunomodulation of a human or animal; decreasing T-cell proliferation |
| 02/13/2003 | US20030031670 Diagnosis and treatment of malignant neoplasms |
| 02/13/2003 | US20030031669 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 02/13/2003 | US20030031664 For therapy of pulmonary embolism, myocardial infarction, thrombosis or stroke |
| 02/13/2003 | US20030031663 Immunogenic polypeptides for inducing anti-self IgE responses |
| 02/13/2003 | US20030031659 For the treatment or prevention of a gastrointestinal infection caused by a pathogenic bacteria; for reducing insect and parasite populations in animal manure |
| 02/13/2003 | US20030031658 Targeting of endosomal growth factor processing as anti-cancer therapy |
| 02/13/2003 | US20030031657 Stem cells and their use in transplantation |
| 02/13/2003 | US20030031656 Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response |
| 02/13/2003 | US20030031655 Methods of light activated release of ligands from endosomes |
| 02/13/2003 | US20030031654 Prohormone convertase transformed cells and polypeptide synthesis |
| 02/13/2003 | US20030031650 Drug inducible system and use thereof |
| 02/13/2003 | US20030031649 Gene therapy to promote angiogenesis |
| 02/13/2003 | US20030031648 Vectors for expressing heterologous peptides at the amino-terminus of potyvirus coat protein, methods for use thereof, plants infected with same and methods of vaccination using same |
| 02/13/2003 | US20030031359 Method and apparatus of measuring three-dimensional posture of sphere and method of measuring rotational amount of sphere and direction of rotational axis thereof |
| 02/13/2003 | US20030029086 Floral packaging material having great masters prints thereon |
| 02/13/2003 | CA2838062A1 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 02/13/2003 | CA2808598A1 Antigenic polypeptides |
| 02/13/2003 | CA2780120A1 Immunologically significant herpes simplex virus antigens and methods for using same |
| 02/13/2003 | CA2494304A1 Materials and methods relating to improved vaccination strategies |
| 02/13/2003 | CA2456229A1 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| 02/13/2003 | CA2456196A1 Compositions and methods for modulation of immune responses |
| 02/13/2003 | CA2456184A1 Expression profile of prostate cancer |
| 02/13/2003 | CA2456105A1 Modular assembly of nucleic acid-protein fusion multimers |
| 02/13/2003 | CA2456050A1 Caax prenyl protease nucleic acids and polypeptides and methods of use thereof |
| 02/13/2003 | CA2456040A1 Method to detect splice variants of the calcineurin gene |
| 02/13/2003 | CA2456003A1 Regulator of calcineurin |
| 02/13/2003 | CA2455918A1 Hagfish cathelin-associated antimicrobial peptides and genes |
| 02/13/2003 | CA2455803A1 Nucleic acid amplification method |
| 02/13/2003 | CA2455700A1 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit |
| 02/13/2003 | CA2455686A1 Methods for generating antibiotic resistant microbes and novel antibiotics |
| 02/13/2003 | CA2455555A1 Animal model for fatty acid amide-related neurobehaviors |
| 02/13/2003 | CA2455462A1 Androgen receptor knock-out transgenic animals |
| 02/13/2003 | CA2455398A1 Use of peptide fragments of the calcium channel .alpha.-1 subunit, optionally comprising mutations, for screening molecules of therapeutic interest |
| 02/13/2003 | CA2455365A1 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |